Email
Emails to Ministers/MEPs requesting meeting with Claus Zieler, CCO Astellas Pharma and Lisa Murphy, General Manager, Astellas Pharma Co. Ltd., at the Astellas Pharma sod-turning event in Munster Technological University on March 25th ,o discuss Astellas' position regarding the proposed reforms to the European General Pharmaceutical legislation and the impact those reforms would have on future investment in the pharmaceutical industry in Europe
Meeting
Meeting with Billy Kelleher, MEP, and Claus Zieler, CCO Astellas Pharma and Lisa Murphy, General Manager, Astellas Pharma Co. Ltd., at the Astellas Pharma sod-turning event in Munster Technological University on March 25th ,to discuss Astellas' position regarding the proposed reforms to the European General Pharmaceutical legislation and the impact those reforms would have on future investment in the pharmaceutical industry in Europe
Meeting
Meeting with Minister for Education Norma Foley and Claus Zieler, CCO Astellas Pharma and Lisa Murphy, General Manager, Astellas Pharma Co. Ltd., at the Astellas Pharma sod-turning event in Munster Technological University on March 25th ,to discuss the broader skills agenda in Ireland and in the EU, and its importance to any robust industrial strategy to ensure the EU can attract pharmaceutical investment and keep pace with other regions of the world.
Meeting
Meeting with Minister for Enterprise, Trade and Employment Simon Coveney and Claus Zieler, CCO Astellas Pharma and Lisa Murphy, General Manager, Astellas Pharma Co. Ltd., at the Astellas Pharma sod-turning event in Munster Technological University on March 25th ,to discuss Astellas' position regarding the proposed reforms to the European General Pharmaceutical legislation and the impact those reforms would have on future investment in the pharmaceutical industry in Europe
Meeting
Meeting with Seán Kelly, MEP, and Claus Zieler, CCO Astellas Pharma and Lisa Murphy, General Manager, Astellas Pharma Co. Ltd., at the Astellas Pharma sod-turning event in Munster Technological University on March 25th ,to discuss Astellas' position regarding the proposed reforms to the European General Pharmaceutical legislation and the impact those reforms would have on future investment in the pharmaceutical industry in Europe
Email
Thank you email to all DPOs mentioned above.